$1,225.00Pre-market+21.68% · 3M
Moving avg
1W+4.33%
1M+3.27%
3M+20.16%
6M+20.22%
YTD+12.97%
1Y+90.87%
3Y+126.86%
5Y+363.24%
52-week range
$623.7895% of range$1,249.45
Company health
Value0/6
Growth5/6
Profitability6/6
Health3/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Strong 32% net margin
- High return on equity (10130%)
- Revenue compounding 12% a year
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$1.15T
Enterprise value
$1.16T
P/E ratio (TTM)
42.41x
P/S ratio (TTM)
15.59x
EV/EBITDA
34.80x
Per share & returns
EPS (TTM)
$28.26
Dividend yield
0.54%
Beta (1Y)
0.51
30-day change
+3.27%
Trading
Volume (24h)
1.53M
Previous close
$1,215.02
Shares outstanding
941.74M
About Eli Lilly and Company
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Symbol
LLY
Eli Lilly and Company is a mega-cap healthcare company in the Drug Manufacturers - General industry. Its shares are listed on NYSE (United States) and trade under the ticker LLY.
Frequently asked questions
What is Eli Lilly and Company's market cap?
Eli Lilly and Company (LLY) has a market capitalization of $1.15T.
What is Eli Lilly and Company's P/E ratio?
Eli Lilly and Company trades at a price-to-earnings (P/E) ratio of 42.41.
What exchange does LLY trade on?
LLY trades on NYSE.
Appears in
Compare & explore
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.50-0.27%
$356.95B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.92-0.23%
$289.77B cap
AstraZeneca PLCLON: AZN
£116.20-0.70%
$242.95B cap
Amgen Inc.AMGN
$416.18+0.45%
$224.62B cap